Hormone Pellets for Women in O’Fallon, MO | AdoreU
Hormone Pellets for Women: Benefits, Risks & What to Expect in O’Fallon, MO
Hot flashes may be the symptom everyone associates with menopause, but for many women, hormone changes feel much bigger than that.
Sleep changes. Energy changes. Sex drive may change. Brain fog can appear out of nowhere. Mood may feel less predictable. Muscle and body composition can shift. And sometimes the hardest thing to explain is simply:
“I just don’t feel like myself.”
Hormone replacement therapy may be an option for women experiencing symptoms during perimenopause and menopause. Hormones can be delivered in several ways, including patches, creams, oral medications, injections, vaginal treatments, troches, and subcutaneous hormone pellets.
At AdoreU in O’Fallon, Missouri, I provide individualized women’s hormone replacement therapy and often prefer pellet therapy for appropriately selected patients.
One of the biggest reasons is practical: once the pellets are inserted, there is no daily cream to apply or injection schedule to remember.
But my personal preference for pellets does not mean they are automatically the best option for every woman.
Understanding how pellets work, what research has shown, their potential risks, and how they compare with other hormone-delivery methods is an important part of making an informed decision.
What Are Hormone Pellets?
Hormone pellets are small, compressed preparations of hormone placed beneath the skin during a brief office procedure.
Depending on a woman’s individual needs, hormone therapy may involve testosterone, estradiol, progesterone, or a combination of therapies.
When progesterone is indicated, it is typically prescribed separately rather than delivered through a pellet.
After insertion, a hormone pellet gradually releases medication over time. Women commonly return for another insertion every few months, although the timing varies between individuals.
That is one of the biggest practical differences between pellets and treatments such as creams, patches, troches, or injections:
There is no daily or weekly medication routine once the pellet has been inserted.
Why Do Some Women Prefer Hormone Pellets?
There is no single hormone-delivery method that works best for every woman.
Each option has advantages and tradeoffs.
For an appropriate candidate, some of the practical reasons for choosing pellets include:
Less Day-to-Day Medication Management
Topical hormones need to be applied consistently.
Patches need to be changed.
Injections require remembering when they are due and being comfortable giving yourself an injection or arranging for someone else to do it.
Pellets remove most of that medication management until it is time for the next insertion.
For women already keeping track of work, family, appointments, medications, groceries, school calendars, and approximately 847 other things, one less thing to remember can be a legitimate advantage.
Sustained Hormone Delivery
Subcutaneous hormone implants are designed to release hormone gradually rather than delivering a single daily or weekly dose.
Testosterone implants have been used in women for decades, and published studies have evaluated their pharmacology, symptom response, and longer-term outcomes.[1-3]
No Risk of Transferring Topical Testosterone to Someone Else
Topical testosterone may be an appropriate choice for some women, but it requires daily application and precautions to reduce accidental transfer to another person through skin contact.
That means thinking about where the medication is applied, allowing it to dry, washing your hands, and being mindful of contact with partners or children.
Pellets eliminate that particular concern.
No Regular Self-Injections
Some women have absolutely no problem giving themselves injections.
Others would rather alphabetize the junk drawer than voluntarily stick themselves with a needle.
Pellet therapy eliminates the need for regular injections at home.
Why I Personally Prefer Hormone Pellets
I think it is helpful for my patients to know that I have not only learned about different hormone-delivery methods from textbooks and medical training.
I have personally used topical hormones, injections, troches, and pellets.
For me, pellets have been the easiest option to live with.
I did not mind topical therapy, but I had to apply it every day and be mindful about making sure the medication did not transfer to anyone else.
Injections were another option, but they still required remembering when it was time for the next dose.
Troches simply were not the best fit for me personally. I did not notice the same benefit from them that I experienced with other methods.
What I appreciate most about pellets is simple:
I don’t have to think about my hormone medication every day or every week.
Once my pellets are inserted, that is one less thing on my list.
My personal experience is one reason I appreciate pellet therapy, but it does not determine what is best for another woman. Your symptoms, health history, treatment goals, risk factors, preferences, and response to therapy matter more than my personal favorite.
What Does the Research Say About Testosterone Pellets in Women?
There is peer-reviewed research evaluating subcutaneous testosterone implants in women, although pellet therapy has not been studied as extensively as some other forms of menopausal hormone therapy.
One study followed 300 pre- and postmenopausal women receiving subcutaneous testosterone implants. The women completed the validated Menopause Rating Scale before treatment and again three months later.
Researchers reported improvement in overall scores as well as psychological, somatic, and urogenital symptom categories after treatment.[1]
Longer-term observational research has also examined breast cancer incidence among women receiving testosterone implants.
A prospective 10-year cohort included 1,267 women treated with subcutaneous testosterone or testosterone combined with an aromatase inhibitor. Researchers reported 11 invasive breast cancers during 6,667 person-years of treatment. The observed breast cancer incidence was lower than the age-matched incidence expected from SEER population data.[2]
A separate study involving 2,377 women receiving testosterone or testosterone plus estradiol pellets also reported a lower observed incidence of invasive breast cancer than expected from age-specific SEER data.[3]
Those findings are reassuring, but they do not prove that testosterone pellets prevent breast cancer.
The studies were not large randomized controlled trials comparing identical groups of women receiving pellets versus placebo. Some women received additional hormonal treatments or aromatase inhibitors, and observational research cannot establish cause and effect in the same way a randomized clinical trial can.
The most accurate conclusion is:
Long-term observational studies of women using testosterone implants have not demonstrated an increased incidence of invasive breast cancer in the populations studied. More controlled long-term research is still needed.
Is Testosterone Only About Sex Drive?
No.
Women naturally produce testosterone, and androgen receptors are found throughout many tissues in the body.
Testosterone has biological relationships with sexual function, muscle, bone, body composition, the nervous system, and other physiologic processes.[4]
Research involving women receiving testosterone implants has also reported improvement across multiple categories of menopause-related symptoms.[1]
However, this is an area where physiology and established treatment indications need to be separated.
The strongest international consensus evidence currently supports systemic testosterone therapy for appropriately evaluated postmenopausal women with hypoactive sexual desire disorder, or HSDD.
There is not yet enough high-quality randomized evidence to say testosterone therapy should routinely be prescribed to women specifically to prevent cardiovascular disease, dementia, osteoporosis, or other chronic diseases.[5]
That does not make testosterone unimportant.
It means we should be careful about the difference between:
“This hormone has important functions throughout the body”
and
“This therapy has been proven to prevent this specific disease.”
Those are not the same statement.
What About Estrogen and Progesterone?
Women's hormone care involves much more than testosterone.
During perimenopause and menopause, treatment may involve estradiol, progesterone, testosterone, or a combination, depending on symptoms, medical history, menstrual status, whether the uterus is present, treatment goals, and individual risk factors.
Estrogen is the most effective hormonal treatment for vasomotor symptoms such as hot flashes and night sweats and also plays an important role in bone and genitourinary health.
When a woman with a uterus receives systemic estrogen, adequate endometrial protection with progesterone or another appropriate progestogen generally also needs to be considered.
Route of administration matters too.
A large BMJ study involving more than 80,000 women with venous thromboembolism and nearly 400,000 controls found increased VTE risk associated with oral hormone therapy, while transdermal preparations were not associated with increased VTE risk in that analysis.[6]
That is one reason hormone therapy should never be reduced to:
“Hormones are good.”
or
“Hormones are dangerous.”
Which hormone, which formulation, which route, which dose, when therapy is started, and which woman is receiving it all matter.
Are Hormone Pellets FDA Approved?
This is an important question, and patients deserve a straightforward answer.
Compounded hormone pellets used for women are not FDA-approved medications.
Compounding can have an important role when a commercially available medication does not meet an individual patient's needs. However, compounded medications do not undergo the same FDA premarket approval process used to verify the safety, effectiveness, potency, and manufacturing consistency of FDA-approved medications.[7]
ACOG currently recommends FDA-approved menopausal hormone therapies when appropriate options are available.
ACOG also specifically recommends considering testosterone preparations other than pellets because long-term safety data remain limited and, unlike a cream or patch, a pellet cannot simply be discontinued once it has been inserted.[8]
That is an important limitation and deserves to be discussed during informed consent.
There are also no FDA-approved testosterone products specifically formulated for women in the United States, which adds another layer of complexity to prescribing testosterone for women.
Good hormone care should include an honest discussion of both the reasons someone may prefer pellets and the limitations of the available evidence.
What Are the Possible Side Effects of Testosterone Pellets?
Possible androgen-related effects can include:
Acne or oilier skin
Increased facial or body hair
Scalp hair changes
Mood changes
Changes in genital tissue
Voice changes, particularly with excessive androgen exposure
The insertion itself also has procedural risks, including:
Bruising
Tenderness
Bleeding
Infection
Pellet extrusion
Temporary activity restrictions while the insertion site heals
Another important difference between a pellet and a cream or patch is reversibility.
If a topical dose needs to be changed, it can usually be adjusted quickly.
A pellet is designed to remain in the tissue and dissolve over time.
That makes appropriate patient selection, dosing, follow-up, and monitoring especially important.
What Happens During Hormone Pellet Insertion?
Pellet insertion is performed in the office.
The treatment area is cleaned and numbed with local anesthetic. A very small incision is made, and the pellet is placed into the subcutaneous tissue using a specialized insertion device.
The incision is then closed and covered.
The procedure itself is usually brief.
Afterward, you receive instructions about keeping the site clean and dry and temporarily avoiding certain strenuous activities while the area heals.
How Long Do Hormone Pellets Last in Women?
Hormone pellets generally provide sustained hormone delivery for several months.
Many women return for another insertion roughly every three to four months, although there is no universal schedule.
Timing can vary based on:
Individual metabolism
Hormone dose
Symptoms
Body composition
Activity level
Previous treatment response
Other health factors
At AdoreU, the goal is not to force every woman onto exactly the same calendar.
Treatment should evolve based on the individual.
Do You Still Need Labs With Hormone Pellet Therapy?
Yes - but laboratory results are only one part of the clinical picture.
Labs can provide useful information for establishing baseline health, evaluating hormone concentrations, monitoring safety, and understanding how someone is responding to treatment.
At the same time, a hormone level should not be interpreted in isolation.
Symptoms, age, menstrual status, health history, medications, SHBG, assay methodology, and treatment response can all affect how laboratory results should be interpreted.
This is particularly important with testosterone testing in women because concentrations are much lower than in men and some assays are less reliable in the female range.
At AdoreU, I look at the combination of:
Your symptoms + your medical history + appropriate laboratory testing + your goals + how you respond to treatment.
We are treating a person, not chasing one pretty number on a lab report.
Are Pellets Better Than Creams, Patches, Injections, or Troches?
I don't think “Which one is best?” is always the right question.
A better question is:
Which delivery method makes the most sense for this particular woman?
A woman who wants the ability to quickly adjust or discontinue medication may prefer a patch or topical therapy.
Someone comfortable with injections may prefer an injectable approach.
Someone who does not want a daily or weekly medication routine may find pellets particularly appealing.
Medical history can also make one option more appropriate than another.
Pellet therapy happens to be my personal preference and a treatment option I often appreciate for appropriate patients.
Preference never replaces individualized medical decision-making.
Who May Be a Candidate for Hormone Pellet Therapy?
A consultation is necessary before deciding whether pellet therapy is appropriate.
Your evaluation may include:
Perimenopause or menopause symptoms
Menstrual and reproductive history
Previous hormone therapy
Personal and family medical history
Breast health history
Cardiovascular and clotting risk
Current medications
Appropriate laboratory testing
Sexual health
Sleep
Energy
Body composition and metabolic health
Your personal treatment preferences
Some women may be appropriate candidates for hormone therapy but better suited to another delivery method.
Others may need additional evaluation before hormone therapy should be considered.
That is why good hormone care should not begin with choosing a product from a menu.
It begins with understanding you.
Hormone Pellet Therapy at AdoreU in O’Fallon, Missouri
At AdoreU, women’s hormone care is individualized rather than built around one predetermined protocol.
We work with women navigating perimenopause, menopause, and other hormone-related changes to understand what has changed, what symptoms are affecting quality of life, and which treatment options make sense medically and practically.
For appropriate patients, hormone pellet therapy may offer an especially convenient option because there is no daily application or regular injection routine.
For another woman, a different delivery method may be the smarter choice.
The goal is not to convince every woman to choose pellets.
If you are looking for personalized women’s hormone replacement therapy in O’Fallon, Missouri, schedule a Women’s Hormone Consultation at AdoreU.
References
Glaser R, York AE, Dimitrakakis C. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas. 2011;68:355-361.
Glaser RL, York AE, Dimitrakakis C. Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study. BMC Cancer. 2019;19:1271.
Donovitz G, Cotten M. Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study. European Journal of Breast Health. 2021;17(2):150-156.
Maclaran K, Panay N. The safety of postmenopausal testosterone therapy. Women's Health. 2012;8(3):263-275.
Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4660-4666.
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810.
U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy. Clinical Consensus No. 6. 2023; reaffirmed 2026.
About the Author
Aleasha Elliott, FNP-C is a board-certified Family Nurse Practitioner and founder of AdoreU in O’Fallon, Missouri. She has been a nurse since 2000 and a Family Nurse Practitioner since 2014. Her approach combines evidence-based medicine, individualized assessment, appropriate laboratory testing, education, and ongoing follow-up to help women and men make informed decisions about hormone optimization.
Medical Disclaimer
This article is provided for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Hormone therapy is not appropriate for everyone. Potential benefits and risks should be evaluated with a qualified healthcare provider based on your individual health history and circumstances.
